TY - JOUR
T1 - Plasma ghrelin suppression as an early predictor for postoperative complications after pancreatoduodenectomy
AU - Sasaki, Kazuki
AU - Asaoka, Tadafumi
AU - Eguchi, Hidetoshi
AU - Fukuda, Yasunari
AU - Iwagami, Yoshifumi
AU - Yamada, Daisaku
AU - Miyazaki, Yasuhiro
AU - Noda, Takehiro
AU - Takahashi, Tsuyoshi
AU - Gotoh, Kunihito
AU - Kawamoto, Koichi
AU - Kurokawa, Yukinori
AU - Kobayashi, Shogo
AU - Takiguchi, Shuji
AU - Mori, Masaki
AU - Doki, Yuichiro
N1 - Funding Information:
This work was partly supported by JSPS KAKENHI Grant Number JP15612402 .
Publisher Copyright:
© 2017 IAP and EPC
PY - 2018/1
Y1 - 2018/1
N2 - Background/Objectives: The gut peptide hormone ghrelin induces appetite and exhibits an anti-inflammatory effect. Serial perioperative changes in ghrelin have been examined in several surgical procedures, but few in pancreatectomy. The present study analyzed perioperative changes in plasma ghrelin levels after pancreaduodenectomy (PD). Methods: The study included 24 patients undergoing PD between May 2015 and January 2016 at Osaka University Hospital. Plasma ghrelin and interleukin-6 (IL-6) levels, as well as white blood cells (WBCs) and C-reactive protein (CRP), were measured preoperatively and on postoperative day (POD) 1, 3, 7, and 14 by enzyme-linked immunosorbent assay. The relationship between the individual ghrelin ratio relative to preoperative value (IGR) and the development of grade IIIa-V Clavien-Dindo (CD) complications was examined. Results: Twelve patients (50%) developed grade IIIa CD complications (n = 6 [25%] pancreatic fistula, n = 7 [29%] intraabdominal abscess, n = 3 [13%] post-pancreatectomy hemorrhage, n = 5 [21%] wound infection, and n = 1 [4%] lymphorrhea). The IGR on POD 1 was significantly lower (p = 0.014) in patients who developed the complications compared to those who did not, but no significant differences were found in terms of WBC, CRP, or IL-6 on POD 1. When the IGR cut-off was set to 82% by receiver operative curve analysis, the sensitivity was 83%, specificity 75% and area under the curve 0.80. The lower IGR group (≤82%) had more postoperative complications and longer hospital stay. Conclusions: The IGR on POD 1 after PD is a useful marker for predicting postoperative complications.
AB - Background/Objectives: The gut peptide hormone ghrelin induces appetite and exhibits an anti-inflammatory effect. Serial perioperative changes in ghrelin have been examined in several surgical procedures, but few in pancreatectomy. The present study analyzed perioperative changes in plasma ghrelin levels after pancreaduodenectomy (PD). Methods: The study included 24 patients undergoing PD between May 2015 and January 2016 at Osaka University Hospital. Plasma ghrelin and interleukin-6 (IL-6) levels, as well as white blood cells (WBCs) and C-reactive protein (CRP), were measured preoperatively and on postoperative day (POD) 1, 3, 7, and 14 by enzyme-linked immunosorbent assay. The relationship between the individual ghrelin ratio relative to preoperative value (IGR) and the development of grade IIIa-V Clavien-Dindo (CD) complications was examined. Results: Twelve patients (50%) developed grade IIIa CD complications (n = 6 [25%] pancreatic fistula, n = 7 [29%] intraabdominal abscess, n = 3 [13%] post-pancreatectomy hemorrhage, n = 5 [21%] wound infection, and n = 1 [4%] lymphorrhea). The IGR on POD 1 was significantly lower (p = 0.014) in patients who developed the complications compared to those who did not, but no significant differences were found in terms of WBC, CRP, or IL-6 on POD 1. When the IGR cut-off was set to 82% by receiver operative curve analysis, the sensitivity was 83%, specificity 75% and area under the curve 0.80. The lower IGR group (≤82%) had more postoperative complications and longer hospital stay. Conclusions: The IGR on POD 1 after PD is a useful marker for predicting postoperative complications.
UR - http://www.scopus.com/inward/record.url?scp=85039053694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039053694&partnerID=8YFLogxK
U2 - 10.1016/j.pan.2017.12.002
DO - 10.1016/j.pan.2017.12.002
M3 - Article
C2 - 29248543
AN - SCOPUS:85039053694
SN - 1424-3903
VL - 18
SP - 73
EP - 78
JO - Pancreatology
JF - Pancreatology
IS - 1
ER -